Obesity is a notable modifiable risk factor for pancreatic cancer and studies have shown that by serving as a second hit, obesogenic HFD drastically promoted oncogenic KRAS-mediated PDAC development, suggesting that pancreatic acinar cells harboring oncogenic KRAS are vulnerable to HFD challenge [12,26]. This evidence concerns the gene KRAS and obesity due to melanocortin 4 receptor deficiency.